Clinical application of dendritic cells in cancer vaccination therapy.
about
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells.Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
P2860
Clinical application of dendritic cells in cancer vaccination therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical application of dendritic cells in cancer vaccination therapy.
@ast
Clinical application of dendritic cells in cancer vaccination therapy.
@en
type
label
Clinical application of dendritic cells in cancer vaccination therapy.
@ast
Clinical application of dendritic cells in cancer vaccination therapy.
@en
prefLabel
Clinical application of dendritic cells in cancer vaccination therapy.
@ast
Clinical application of dendritic cells in cancer vaccination therapy.
@en
P2860
P1476
Clinical application of dendritic cells in cancer vaccination therapy.
@en
P2093
Mette Line Soot
Søren Buus
P2860
P304
P356
10.1034/J.1600-0463.2003.11107813.X
P577
2003-07-01T00:00:00Z